| 1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-3,12 % |
+18,76 % |
-0,29 |
| 2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,77 % |
+20,45 % |
-0,34 |
| 3 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-3,62 % |
+19,58 % |
-0,30 |
| 4 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-4,99 % |
+20,44 % |
-0,35 |
| 5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-5,02 % |
+20,30 % |
-0,36 |
|
|
| 75 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
-17,88 % |
+22,95 % |
-0,88 |
|
|
| 79 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-11,17 % |
+12,00 % |
-1,12 |
| 80 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-35,90 % |
+30,91 % |
-1,23 |
| 81 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-36,10 % |
+30,90 % |
-1,24 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-15,46 % |
+13,82 % |
-1,28 |
| 83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-16,05 % |
+13,82 % |
-1,33 |